Article History
First Online: 20 May 2020
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Ashwin Somasundaram declares that he has no conflicts of interest that might be relevant to this article. Mark A. Socinski reports honoraria from AstraZeneca, Bristol-Myers Squibb, Celgene, and Genentech; a consultancy/advisory role with Genentech; speakers’ bureau from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech; and research funding from Genentech and Pfizer (institute funding). Liza C. Villaruz reports receiving fees for speaker or advisory board roles for Pfizer.